Rheumatoid arthritis synovium contains plasmacytoid dendritic cells.
We have previously described enrichment of antigen-presenting HLA-DR+ nuclear RelB+ dendritic cells (DCs) in rheumatoid arthritis (RA) synovium. CD123+HLA-DR+ plasmacytoid DCs (pDCs) and their precursors have been identified in human peripheral blood (PB), lymphoid tissue, and some inflamed tissues. We hypothesized recruitment of pDCs into the inflamed RA synovial environment and their contribution as antigen-presenting cells (APCs) and inflammatory cells in RA. CD11c+ myeloid DCs and CD123+ pDCs were compared in normal and RA PB, synovial fluid (SF), and synovial tissue by flow cytometry, immunohistochemistry, and electron microscopy and were sorted for functional studies. Nuclear RelB-CD123+ DCs were located in perivascular regions of RA, in a similar frequency to nuclear RelB+CD123- DCs, but not normal synovial tissue sublining. Apart from higher expression of HLA-DR, the numbers and phenotypes of SF pDCs were similar to those of normal PB pDCs. While the APC function of PB pDCs was less efficient than that of PB myeloid DCs, RA SF pDCs efficiently activated resting allogeneic PB T cells, and high levels of IFN-gamma, IL-10, and tumor necrosis factor alpha were produced in response to incubation of allogeneic T cells with either type of SF DCs. Thus, pDCs are recruited to RA synovial tissue and comprise an APC population distinct from the previously described nuclear RelB+ synovial DCs. pDCs may contribute significantly to the local inflammatory environment.
Cavanagh
Lois L
LL
Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
Boyce
Amanda
A
Smith
Louise
L
Padmanabha
Jagadish
J
Filgueira
Luis
L
Pietschmann
Peter
P
Thomas
Ranjeny
R
D017951:Antigen Presentation; D015535:Arthritis, Psoriatic / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology*; D001327:Autoimmune Diseases / Q000276:immunology / Q000473:pathology*; D039521:CD11c Antigen / Q000032:analysis; D002452:Cell Count; D002454:Cell Differentiation; D002478:Cells, Cultured / Q000276:immunology; D016207:Cytokines / Q000032:analysis; D003713:Dendritic Cells / Q000145:classification / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007124:Immunoenzyme Techniques; D053650:Interleukin-3 Receptor alpha Subunit; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D016185:Receptors, Interleukin-3 / Q000032:analysis; D013167:Spondylitis, Ankylosing / Q000473:pathology; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D051841:Transcription Factor RelB / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D039521:CD11c Antigen; D016207:Cytokines; C115022:IL3RA protein, human; D053650:Interleukin-3 Receptor alpha Subunit; C497593:RELB protein, human; D016185:Receptors, Interleukin-3; D014409:Tumor Necrosis Factor-alpha; D051841:Transcription Factor RelB
Arthritis Rheum. 1996 Jul;39(7):1077-81
8670314
Nat Med. 1999 Aug;5(8):919-23
10426316
Blood. 1996 Oct 15;88(8):3010-21
8874199
Arthritis Rheum. 1996 Dec;39(12):1970-9
8961901
J Exp Med. 1997 Mar 17;185(6):1101-11
9091583
J Invest Dermatol. 1997 Apr;108(4):445-51
9077472
J Immunol. 1997 Oct 15;159(8):3681-91
9378953
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12551-6
9356487
J Clin Invest. 1997 Nov 1;100(9):2404-14
9410920
J Immunol. 1998 Apr 1;160(7):3585-93
9531322
Blood. 1998 Sep 1;92(5):1598-607
9716587
Oncogene. 2001 Dec 6;20(56):8142-7
11781828
J Immunol. 1999 Sep 15;163(6):3250-9
10477594
J Immunol. 2000 Apr 15;164(8):3955-9
10754285
Arthritis Rheum. 2000 Apr;43(4):791-800
10765923
J Exp Med. 2000 Jul 17;192(2):219-26
10899908
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11421-6
11027342
J Immunol. 2000 Oct 1;165(7):4062-8
11034417
Arthritis Rheum. 2000 Oct;43(10):2160-8
11037875
J Immunol. 2000 Dec 1;165(11):6037-46
11086035
J Exp Med. 2000 Dec 18;192(12):1785-96
11120775
Arthritis Rheum. 2001 Jan;44(1):105-10
11212147
J Immunol. 2001 Feb 15;166(4):2291-5
11160284
Brain. 2001 Mar;124(Pt 3):480-92
11222448
Nat Immunol. 2000 Oct;1(4):305-10
11017101
J Immunol. 2001 Apr 15;166(8):5000-7
11290780
Am J Pathol. 2001 Jul;159(1):237-43
11438470
Eur J Immunol. 2001 Sep;31(9):2547-57
11536152
J Exp Med. 2001 Sep 17;194(6):863-9
11561001
Eur J Immunol. 2001 Oct;31(10):3026-37
11592079
Rheumatology (Oxford). 2001 Nov;40(11):1243-55
11709608
Nat Med. 2001 Dec;7(12):1339-46
11726975
J Exp Med. 2002 Mar 18;195(6):695-704
11901196
Immunol Cell Biol. 2002 Apr;80(2):164-9
11940117
J Immunol. 2002 May 15;168(10):5333-41
11994492
J Immunol. 2002 Jun 1;168(11):5491-8
12023343
J Immunol. 2002 Dec 1;169(11):6079-83
12444109
J Immunol. 2003 May 1;170(9):4638-48
12707342
N Engl J Med. 2003 Apr 24;348(17):1709-11
12711748
J Pathol. 2003 Jun;200(2):255-68
12754747
J Exp Med. 2003 Sep 1;198(5):823-30
12953097
Arthritis Rheum. 2003 Sep;48(9):2524-32
13130472
J Exp Med. 2004 Jan 19;199(2):173-83
14734523
Rheumatology (Oxford). 2004 Apr;43(4):453-60
14762226
J Immunol. 2004 Aug 15;173(4):2815-24
15295000
J Immunol. 1987 May 15;138(10):3319-24
3494766
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
J Immunol. 1994 Mar 1;152(5):2613-23
7510751
J Exp Med. 1994 Apr 1;179(4):1331-6
8145044
Arthritis Rheum. 1995 Jan;38(1):96-104
7818579
J Exp Med. 1995 Apr 1;181(4):1275-83
7699319
J Immunol. 1996 Apr 15;156(8):3074-86
8609431
Clin Exp Immunol. 1996 Mar;103(3):357-67
8608632
J Exp Med. 1998 Oct 19;188(8):1493-501
9782126
Ann Rheum Dis. 1998 Aug;57(8):480-6
9797554
J Immunol. 1998 Dec 1;161(11):6390-7
9834130
Springer Semin Immunopathol. 1998;20(1-2):211-28
9836378
Springer Semin Immunopathol. 1998;20(1-2):229-46
9836379
J Immunol. 1999 Mar 1;162(5):3053-62
10072558
Arthritis Rheum. 1999 Mar;42(3):507-18
10088774
Science. 1999 Jun 11;284(5421):1835-7
10364556
Arthritis Rheum. 1996 Jul;39(7):1082-91
8670315